Piramal Pharma reports consolidated net profit of Rs 5.58 crore in the September 2026 quarter

Sales rise 28.05% to Rs 2617.06 crore

Net profit of Piramal Pharma reported to Rs 5.58 crore in the quarter ended September 2026 as against net loss of Rs 99.22 crore during the previous quarter ended September 2025. Sales rose 28.05% to Rs 2617.06 crore in the quarter ended September 2026 as against Rs 2043.72 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	2617.06	2043.72	28
OPM %	13.33	7.76	-
PBDT	314.78	156.66	101
PBT	81.63	-46.18	LP
NP	5.58	-99.22	LP

Powered by Capital Market - Live News